BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1378984)

  • 1. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas.
    Shoji T; Kamiya T; Tsubura A; Hatano T; Sakakura T; Yamamoto M; Morii S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):53-6. PubMed ID: 1378984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
    Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
    Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
    Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
    Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
    Shoji T; Kamiya T; Tsubura A; Hamada Y; Hatano T; Hioki K; Morii S
    J Surg Res; 1993 Sep; 55(3):295-7. PubMed ID: 7692137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
    Gould VE; Koukoulis GK; Virtanen I
    Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
    Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
    J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin expression in normal human adult skin and skin appendage tumours.
    Shikata N; Oyaizu T; Andachi H; Tsubura A
    Virchows Arch; 1994; 424(5):511-6. PubMed ID: 7518292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
    Jones JL; Critchley DR; Walker RA
    J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
    Ishihara A; Yatani R; Sakakura T
    Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma.
    Ferguson JE; Schor AM; Howell A; Ferguson MW
    Differentiation; 1990 Feb; 42(3):199-207. PubMed ID: 1692795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis?
    Yoshida T; Ishihara A; Hirokawa Y; Kusakabe M; Sakakura T
    Cancer Lett; 1995 Mar; 90(1):65-73. PubMed ID: 7536626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin expression in normal and abnormal human endometrium.
    Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
    Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.
    Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
    Br J Cancer; 1995 Jul; 72(1):189-92. PubMed ID: 7541237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.
    Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M
    Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study.
    Miyazaki H; Van Eyken P; Roskams T; De Vos R; Desmet VJ
    J Hepatol; 1993 Nov; 19(3):353-66. PubMed ID: 7512109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of tenascin in stomach cancer. An immunohistochemical study].
    Broll R; Kayser K; Vollmer G; Plagemann M; Bruch HP
    Zentralbl Pathol; 1994 Jul; 140(2):123-8. PubMed ID: 7524650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.
    Sunardhi-Widyaputra S; Van Damme B
    Pathol Res Pract; 1993 Mar; 189(2):138-43. PubMed ID: 7686669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study].
    Yano S
    Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.